Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,501.24
(
0.77%
)
US TECH 100
28,319.60
(
-1.64%
)
Dow Jones
50,063.46
(
0.75%
)
Brent Oil
106.60
(
2.32%
)
Bitcoin
80,456.92
(
-0.74%
)
News Focus
News Focus
Post# of 257566
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122982
Boards Moderated 9
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 80227

Friday, 08/28/2009 12:56:39 AM

Friday, August 28, 2009 12:56:39 AM

Post# of 257566
Biolex taps Cook Pharmica to manufacture Locteron for phase-3 trials (and presumably for commercialization if the phase-3 trials are successful):

http://finance.yahoo.com/news/Biolex-Therapeutics-Selects-iw-3953994604.html?x=0&.v=1

Locteron is a long-acting interferon alpha for HCV derived from transgenic plants.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today